Zhejiang Tianyu Pharmaceutical Co., Ltd.
SHZ: 300702.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yong Jun Tu
- Employees
- 4,690
- Headquarters
- Taizhou, China
- IPO year
- 2017
- Market cap
- CN¥7.3B
- Website
- https://www.tianyupharm.com
Loading 300702…
Loading profile data…Frequently asked questions about 300702
What does Zhejiang Tianyu Pharmaceutical Co., Ltd. (300702.SZ) do?
Zhejiang Tianyu Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally. The company offers pharmaceutical intermediates and APIs of cardiovascular, anti-diabetic, anti-atherosclerosis, anticoagulant, and anti-asthmatic series. It also provides fin...
Where does 300702.SZ trade?
Zhejiang Tianyu Pharmaceutical Co., Ltd. (300702.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300702.SZ in?
Zhejiang Tianyu Pharmaceutical Co., Ltd. (300702.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Zhejiang Tianyu Pharmaceutical Co., Ltd.?
Yong Jun Tu is the chief executive officer of Zhejiang Tianyu Pharmaceutical Co., Ltd. (300702.SZ).
Where is Zhejiang Tianyu Pharmaceutical Co., Ltd. headquartered?
Zhejiang Tianyu Pharmaceutical Co., Ltd. is headquartered in China.
Does 300702.SZ pay a dividend?
Yes — Zhejiang Tianyu Pharmaceutical Co., Ltd. (300702.SZ) paid a trailing twelve-month dividend of CNY 0.05 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300702.SZ go public?
Zhejiang Tianyu Pharmaceutical Co., Ltd. (300702.SZ) completed its initial public offering in 2017.